SPTX · Seaport Therapeutics, Inc.
$24.04
-0.39 (-1.58%)
At close · Aug 20
Market Cap
$1.29B
Shares
53.53M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$24.04
Open$24.12
Day$23.53–25.45
Available close range$15.25–24.42
Avg vol 30d112K
Short int2.8M · 5.2% float · 30.8d
Short vol72%
Last earningsAug 3, 2026
DataMay 2026–Aug 2026
Filing10-Q · Aug 3
The closing range uses available history since May 1, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 3, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+15%
above
RSI (14)
62
neutral
MACD trend
Positive
52-week position
96%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+54 funds added
Insider flow
Accumulating
Net +$235.8K over 90 days · 0% sells
Short interest
Rising
5.15% of float · ▲ +39.3% MoM · 30.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
54 holders — 13F breadth
Squeeze score
85
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+15%
Bullish
RSI (14)
62
Neutral
MACD trend
Positive
Bullish
52-week position
96%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+54 funds added
Insider flow
Accumulating
Net +$235.8K over 90 days · 0% sells
Short interest
Rising
5.15% of float · ▲ +39.3% MoM · 30.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
54 holders — 13F breadth
Price context
position in its available closing range
Range low $15
Now $24 · 96%
Range high $24
vs 50-day avg +15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, cash equivalents, and investments | $427.3M | Q2 2026 | — |
| IPO gross proceeds | $260M | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SPTX
this stock
Seaport Therapeutics, Inc.
|
$1.29B | — | — | — | 5.2% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SPTX | +1.4% | +9.6% | — | +17.5% | — |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +3.3% | +6.2% | — | +15.4% | — |
Key facts
CIK
2042347
CUSIP
81221K108
13F (30d)
57 filings
57 filers
Visit website
Investor relations